130 related articles for article (PubMed ID: 35263886)
21. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.
Pollack IF; Hamilton RL; James CD; Finkelstein SD; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL;
J Neurosurg; 2006 Nov; 105(5 Suppl):418-24. PubMed ID: 17328268
[TBL] [Abstract][Full Text] [Related]
22. Detection and Correlation of Single and Concomitant
Pessôa IA; Amorim CK; Ferreira WAS; Sagica F; Brito JR; Othman M; Meyer B; Liehr T; de Oliveira EHC
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151164
[TBL] [Abstract][Full Text] [Related]
23. The expression of PAX6, PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: relationship to tumor grade and survival.
Zhou YH; Tan F; Hess KR; Yung WK
Clin Cancer Res; 2003 Aug; 9(9):3369-75. PubMed ID: 12960124
[TBL] [Abstract][Full Text] [Related]
24. Characterisation of molecular alterations in microdissected archival gliomas.
Walker C; Joyce KA; Thompson-Hehir J; Davies MP; Gibbs FE; Halliwell N; Lloyd BH; Machell Y; Roebuck MM; Salisbury J; Sibson DR; Du Plessis D; Broome J; Rossi ML
Acta Neuropathol; 2001 Apr; 101(4):321-33. PubMed ID: 11355303
[TBL] [Abstract][Full Text] [Related]
25. Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas.
Fults D; Pedone C
Neuro Oncol; 2000 Apr; 2(2):71-9. PubMed ID: 11303623
[TBL] [Abstract][Full Text] [Related]
26. Functional evaluation of p53 and PTEN gene mutations in gliomas.
Kato H; Kato S; Kumabe T; Sonoda Y; Yoshimoto T; Kato S; Han SY; Suzuki T; Shibata H; Kanamaru R; Ishioka C
Clin Cancer Res; 2000 Oct; 6(10):3937-43. PubMed ID: 11051241
[TBL] [Abstract][Full Text] [Related]
27. Molecular genetic profiling reveals novel association between FLT3 mutation and survival in glioma.
Shee K; Chambers M; Hughes EG; Almiron DA; Deharvengt SJ; Green D; Lefferts JA; Andrew AS; Hickey WF; Tsongalis GJ
J Neurooncol; 2020 Jul; 148(3):473-480. PubMed ID: 32583303
[TBL] [Abstract][Full Text] [Related]
28. High-grade glioma formation results from postnatal pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model.
Wei Q; Clarke L; Scheidenhelm DK; Qian B; Tong A; Sabha N; Karim Z; Bock NA; Reti R; Swoboda R; Purev E; Lavoie JF; Bajenaru ML; Shannon P; Herlyn D; Kaplan D; Henkelman RM; Gutmann DH; Guha A
Cancer Res; 2006 Aug; 66(15):7429-37. PubMed ID: 16885338
[TBL] [Abstract][Full Text] [Related]
29. Glioma stem cells-derived exosomal miR-26a promotes angiogenesis of microvessel endothelial cells in glioma.
Wang ZF; Liao F; Wu H; Dai J
J Exp Clin Cancer Res; 2019 May; 38(1):201. PubMed ID: 31101062
[TBL] [Abstract][Full Text] [Related]
30. Malignant glioma: the involvement of loss of allelic heterozygosity and PTEN mutations in a group of Malay patients.
Zainuddin N; Jaafar H; Isa MN; Abdullah JM
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):748-56. PubMed ID: 16124450
[TBL] [Abstract][Full Text] [Related]
31. ACTC1 as an invasion and prognosis marker in glioma.
Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O
J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897
[TBL] [Abstract][Full Text] [Related]
32. ARL4C stabilized by AKT/mTOR pathway promotes the invasion of PTEN-deficient primary human glioblastoma.
Chen Q; Weng HY; Tang XP; Lin Y; Yuan Y; Li Q; Tang Z; Wu HB; Yang S; Li Y; Zhao XL; Fu WJ; Niu Q; Feng H; Zhang X; Wang Y; Bian XW; Yao XH
J Pathol; 2019 Feb; 247(2):266-278. PubMed ID: 30357833
[TBL] [Abstract][Full Text] [Related]
33. Relationship between PTEN gene expression and differentiation of human glioma.
Yang Y; Shao N; Luo G; Li L; Nilsson-Ehle P; Xu N
Scand J Clin Lab Invest; 2006; 66(6):469-75. PubMed ID: 17000554
[TBL] [Abstract][Full Text] [Related]
34. Over-expression of lysyl oxidase is associated with poor prognosis and response to therapy of patients with lower grade gliomas.
Huang SP; Chiou J; Jan YH; Lai TC; Yu YL; Hsiao M; Lin YF
Biochem Biophys Res Commun; 2018 Jun; 501(3):619-627. PubMed ID: 29729273
[TBL] [Abstract][Full Text] [Related]
35. Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations.
Zhou XP; Li YJ; Hoang-Xuan K; Laurent-Puig P; Mokhtari K; Longy M; Sanson M; Delattre JY; Thomas G; Hamelin R
Int J Cancer; 1999 Apr; 84(2):150-4. PubMed ID: 10096247
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive protein tyrosine phosphatase mRNA profiling identifies new regulators in the progression of glioma.
Bourgonje AM; Verrijp K; Schepens JT; Navis AC; Piepers JA; Palmen CB; van den Eijnden M; Hooft van Huijsduijnen R; Wesseling P; Leenders WP; Hendriks WJ
Acta Neuropathol Commun; 2016 Sep; 4(1):96. PubMed ID: 27586084
[TBL] [Abstract][Full Text] [Related]
37. The Prognostic Value of MRI Subventricular Zone Involvement and Tumor Genetics in Lower Grade Gliomas.
Chiang GC; Pisapia DJ; Liechty B; Magge R; Ramakrishna R; Knisely J; Schwartz TH; Fine HA; Kovanlikaya I
J Neuroimaging; 2020 Nov; 30(6):901-909. PubMed ID: 32721076
[TBL] [Abstract][Full Text] [Related]
38. miR-132-3p boosts caveolae-mediated transcellular transport in glioma endothelial cells by targeting PTEN/PI3K/PKB/Src/Cav-1 signaling pathway.
Gu Y; Cai R; Zhang C; Xue Y; Pan Y; Wang J; Zhang Z
FASEB J; 2019 Jan; 33(1):441-454. PubMed ID: 30024792
[TBL] [Abstract][Full Text] [Related]
39. Investigation of MMAC/PTEN gene mutations and protein expression in low grade gliomas.
Cecener G; Tunca B; Egeli U; Bekar A; Guler G; Vatan O; Tolunay S
Cell Mol Neurobiol; 2009 Jul; 29(5):733-8. PubMed ID: 19350382
[TBL] [Abstract][Full Text] [Related]
40. Impact of novel PTEN mutations in Turkish patients with glioblastoma multiforme.
Tunca B; Bekar A; Cecener G; Egeli U; Vatan O; Tolunay S; Kocaeli H; Aksoy K
J Neurooncol; 2007 May; 82(3):263-9. PubMed ID: 17151929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
